Register Login

CERIBELL, INC. (CBLL)

SymbolCBLL
NameCERIBELL, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
Address360 N. PASTORIA AVENUE, SUNNYVALE, California, 94085, United States
Telephone+1 800 436-0826
Fax—
Email—
Websitehttps://www.ceribell.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001861107
Description

CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients.

Additional info from NASDAQ:
CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients.

2026-07-30 23:43

West Thomas A. 🟢 acquired 16.0K shares of Ceribell, Inc. (CBLL) Transaction Date: Jul 28, 2026 | Filing ID: 326487

Read more
2026-07-30 23:39

O'KEEFE SHARON 🟢 acquired 16.0K shares of Ceribell, Inc. (CBLL) Transaction Date: Jul 28, 2026 | Filing ID: 326486

Read more
2026-07-30 20:45

New Form 3 - Ceribell, Inc. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001193125-26-326489 <b>Size:</b> 25 KB

Read more
2026-07-30 20:38

New Form 3 - Ceribell, Inc. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001193125-26-326483 <b>Size:</b> 25 KB

Read more
2026-07-29 11:00

Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe

Read more
2026-07-28 20:05

Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference

Read more
2026-07-20 20:05

Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026

Read more
2026-07-09 16:34

Chao Xingjuan 🟡 adjusted position in 39.0K shares (2 derivative) of Ceribell, Inc. (CBLL) at $19.90 ($1.0M) Transaction Date: Jul 07, 2026 | Filing ID: 299427

Read more
2026-07-07 14:01

📋 Chao Xingjuan (Officer) plans to sell 39K shares of Ceribell, Inc. (at $20.00 each, total $780K) Filed: Jul 07, 2026 | ID: 005131

Read more
2026-07-02 16:08

BURKE WILLIAM W 🔴 sold 2.2K shares of Ceribell, Inc. (CBLL) at $19.84 Transaction Date: Jun 30, 2026 | Filing ID: 293917

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT07485244 EEG Abnormalities in Adult ICU Patients With High Risk of Delirium — Delirium in the Intensive Care Unit Recruiting 2026-04-16 2027-09-30 ClinicalTrials.gov
NCT07449416 Ceribell Delirium Monitor Outcomes Pilot Study Na Delirium in the Intensive Care Unit Recruiting 2026-03-15 2026-12-01 ClinicalTrials.gov
Total clinical trials: 2
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Ceribell Delirium Monitoring System Other Approved Delirium in the Intensive Care Unit RECRUITING NCT07449416
Ceribell Delirium Monitoring System Other Approved Delirium in the Intensive Care Unit NOT_YET_RECRUITING NCT07449416
Ceribell EEG System Other Preclinical Delirium in the Intensive Care Unit RECRUITING NCT07485244
Ceribell EEG System Other Preclinical Delirium in the Intensive Care Unit RECRUITING NCT07485244
Ceribell EEG System Other Preclinical Delirium in the Intensive Care Unit RECRUITING NCT07485244
Ceribell EEG System Other Preclinical Delirium in the Intensive Care Unit RECRUITING NCT07485244
Ceribell EEG System Other Preclinical Delirium in the Intensive Care Unit RECRUITING NCT07485244
Ceribell EEG System Other Preclinical Delirium in the Intensive Care Unit RECRUITING NCT07485244
Ceribell EEG System Other Preclinical Delirium in the Intensive Care Unit RECRUITING NCT07485244
Ceribell EEG System Other Preclinical Delirium in the Intensive Care Unit RECRUITING NCT07485244
Ceribell EEG System Other Preclinical Delirium in the Intensive Care Unit RECRUITING NCT07485244
Total products: 11